Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

The U.S. Food and Drug Administration said a comprehensive review “found no increased” risk related to suicide among users of the GLP-1 drugs for obesity, including Novo Nordisk’s Wegovy and Saxenda ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

The Food and Drug Administration (FDA) is seeking to remove suicide warnings from several popular weight-loss medications, ...

The FDA said it wants suicide warnings to be taken off some popular weight-loss medications following a comprehensive safety ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Request based on a comprehensive review of data ...

The U.S. Food and Drug Administration ‍on Tuesday requested companies to remove warnings related to the ‌potential risk ‌of ...

(CNN)– The Food and Drug Administration (FDA) wants suicide warnings to be taken off of some popular weight-loss medications.

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...